Evidence map›Paper›PMID 38773050›Full record

ArticlePharmacoEconomics - open2024

Mapping Payment and Pricing Schemes for Health Innovation: Protocol of a Scoping Literature Review.

Vittoria Ardito, Ludovico Cavallaro, Michael Drummond, Oriana Ciani

Abstract read
In one paragraph

Article in PharmacoEconomics - open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Vittoria ArditoCenter for Research on Health and Social Care Management, SDA Bocconi School of Management, Via Sarfatti, 10, 20136, Milan, MI, Italy. vittoria.ardito@sdabocconi.it.ORCID http://orcid.org/0000-0003-2034-716X
Ludovico CavallaroCenter for Research on Health and Social Care Management, SDA Bocconi School of Management, Via Sarfatti, 10, 20136, Milan, MI, Italy.ORCID http://orcid.org/0009-0002-3426-2570
Michael DrummondCenter for Research on Health and Social Care Management, SDA Bocconi School of Management, Via Sarfatti, 10, 20136, Milan, MI, Italy.ORCID http://orcid.org/0000-0002-6126-0944
Oriana CianiCenter for Research on Health and Social Care Management, SDA Bocconi School of Management, Via Sarfatti, 10, 20136, Milan, MI, Italy.ORCID http://orcid.org/0000-0002-3607-0508

Funding

HORIZON EUROPE Framework Programme 101095593
6 · The paper itself

Abstract

introductionInnovative pricing and payment/reimbursement schemes have been proposed as one part of the solution to the problem of patient access to new health technologies or to the uncertainty about their long-term effectiveness. As part of a Horizon Europe research project on health innovation next generation pricing and payment models (HI-PRIX), this protocol illustrates the conceptual and methodological steps related to a scoping review aiming at investigating nature and scope of pricing and payment/reimbursement schemes applied to, or proposed for, existing or new health technologies.

methodsA scoping review of literature will be performed according to the PRISMA guidelines for scoping reviews (PRISMA-ScR) guidelines. The search will be conducted in three scientific databases (i.e., PubMed, Web of Science, and Scopus), over a 2010-2023 timeframe. The search strategy is structured around two blocks of keywords, namely "pricing and payment/reimbursement schemes," and "innovativeness" (of the scheme type or scheme use). A simplified search will be replicated in the gray literature. Studies illustrating pricing and payment/reimbursement schemes with a sufficient level of details to explain their characteristics and functioning will be deemed eligible to be considered for data synthesis. Pricing and payment/reimbursement schemes will be classified according to several criteria, such as their purpose, nature, governance, data collection needs, and foreseen distribution of risk. The results will populate a publicly available online tool, the Pay-for-Innovation Observatory. DISCUSSION: The findings of this review have the potential to offer a comprehensive toolkit with a variety of pricing and payment schemes to policymakers and manufacturers facing reimbursement and access decisions.

Identifiers

PMID38773050
PMCPMC11362434

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.